Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.

Sandhoff disease is a severe neurodegenerative glycosphingolipid (GSL) lysosomal storage disorder, currently without treatment options. One therapeutic approach under investigation is substrate reduction therapy (SRT). By partially inhibiting GSL biosynthesis, the impaired rate of GSL catabolism is...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Andersson, U, Smith, D, Jeyakumar, M, Butters, T, Borja, M, Dwek, R, Platt, F
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2004

Ижил төстэй зүйлс

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease
-н: Ulrika Andersson, зэрэг
Хэвлэсэн: (2004-08-01)

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
-н: Jeyakumar, M, зэрэг
Хэвлэсэн: (2004)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
-н: Andersson, U, зэрэг
Хэвлэсэн: (2000)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
-н: Baek, R, зэрэг
Хэвлэсэн: (2004)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
-н: Baek, R, зэрэг
Хэвлэсэн: (2008)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
-н: Platt, F, зэрэг
Хэвлэсэн: (2003)

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.
-н: Jeyakumar, M, зэрэг
Хэвлэсэн: (2001)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
-н: Kasperzyk, J, зэрэг
Хэвлэсэн: (2004)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
-н: Kasperzyk, J, зэрэг
Хэвлэсэн: (2004)

Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
-н: Baek, R, зэрэг
Хэвлэсэн: (2005)

MRS reveals additional hexose N-acetyl resonances in the brain of a mouse model for Sandhoff disease.
-н: Lowe, J, зэрэг
Хэвлэсэн: (2005)

Substrate reduction therapy in Sandhoff disease: Evidence for improvement in nervous function in patients treated with miglustat
-н: Lachmann, R, зэрэг
Хэвлэсэн: (2006)

Analysis of stored oligosaccharides in a mouse model of a glycolipid storage (Sandhoff) disease
-н: Awan, F, зэрэг
Хэвлэсэн: (2003)

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.
-н: Elliot-Smith, E, зэрэг
Хэвлэсэн: (2008)

Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin.
-н: Pelled, D, зэрэг
Хэвлэсэн: (2003)

Beneficial effects of acetyl-DL-Leucine (ADLL) in a mouse model of Sandhoff disease
-н: Kaya, E, зэрэг
Хэвлэсэн: (2020)

New developments in treating glycosphingolipid storage diseases.
-н: Platt, F, зэрэг
Хэвлэсэн: (2005)

Substrate reduction therapy
-н: Platt, F, зэрэг
Хэвлэсэн: (2007)

Substrate reduction therapy.
-н: Platt, F, зэрэг
Хэвлэсэн: (2008)

Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.
-н: Rountree, J, зэрэг
Хэвлэсэн: (2009)

Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
-н: Denny, C, зэрэг
Хэвлэсэн: (2010)

Infantile Sandhoff's disease
-н: K Sass, зэрэг
Хэвлэсэн: (2009-08-01)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
-н: Jeyakumar, M, зэрэг
Хэвлэсэн: (2002)

Storage solutions: treating lysosomal disorders of the brain.
-н: Jeyakumar, M, зэрэг
Хэвлэсэн: (2005)

An inducible mouse model of late onset Tay-Sachs disease.
-н: Jeyakumar, M, зэрэг
Хэвлэсэн: (2002)

Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease.
-н: Richardson, K, зэрэг
Хэвлэсэн: (2016)

Efficacy of a Bicistronic Vector for Correction of Sandhoff Disease in a Mouse Model
-н: Evan Woodley, зэрэг
Хэвлэсэн: (2019-03-01)

Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
-н: Nick Platt, зэрэг
Хэвлэсэн: (2025-01-01)

Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
-н: te Vruchte, D, зэрэг
Хэвлэсэн: (2010)

An Inducible Mouse Model of Late Onset Tay–Sachs Disease
-н: Mylvaganam Jeyakumar, зэрэг
Хэвлэсэн: (2002-08-01)

Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
-н: Andersson, U, зэрэг
Хэвлэсэн: (2004)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
-н: Platt, F, зэрэг
Хэвлэсэн: (2001)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
-н: van der Spoel, A, зэрэг
Хэвлэсэн: (2002)

Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease.
-н: Karen M Ashe, зэрэг
Хэвлэсэн: (2011-01-01)

Decrease in Myelin-Associated Lipids Precedes Neuronal Loss and Glial Activation in the CNS of the Sandhoff Mouse as Determined by Metabolomics
-н: Emmanuelle Lecommandeur, зэрэг
Хэвлэсэн: (2020-12-01)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
-н: Mellor, H, зэрэг
Хэвлэсэн: (2003)

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
-н: Jeyakumar, M, зэрэг
Хэвлэсэн: (2003)

Impaired neural differentiation of induced pluripotent stem cells generated from a mouse model of Sandhoff disease.
-н: Yasuhiro Ogawa, зэрэг
Хэвлэсэн: (2013-01-01)

Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage.
-н: Yasuhiro Ogawa, зэрэг
Хэвлэсэн: (2017-01-01)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
-н: Priestman, D, зэрэг
Хэвлэсэн: (2008)